- Home
- GLSI vs DSP Comparison
GLSI vs DSP Comparison
Compare GLSI & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLSI
- DSP
- Stock Information
- Founded
- GLSI 2006
- DSP 1999
- Country
- GLSI United States
- DSP United States
- Employees
- GLSI N/A
- DSP N/A
- Industry
- GLSI Biotechnology: Pharmaceutical Preparations
- DSP EDP Services
- Sector
- GLSI Health Care
- DSP Technology
- Exchange
- GLSI Nasdaq
- DSP Nasdaq
- Market Cap
- GLSI 149.5M
- DSP 142.1M
- IPO Year
- GLSI 2020
- DSP 2021
- Fundamental
- Price
- GLSI $11.28
- DSP $8.62
- Analyst Decision
- GLSI Strong Buy
- DSP Strong Buy
- Analyst Count
- GLSI 1
- DSP 9
- Target Price
- GLSI $39.00
- DSP $20.44
- AVG Volume (30 Days)
- GLSI 91.0K
- DSP 324.6K
- Earning Date
- GLSI 11-13-2025
- DSP 11-11-2025
- Dividend Yield
- GLSI N/A
- DSP N/A
- EPS Growth
- GLSI N/A
- DSP N/A
- EPS
- GLSI N/A
- DSP 0.13
- Revenue
- GLSI N/A
- DSP $318,471,000.00
- Revenue This Year
- GLSI N/A
- DSP $16.44
- Revenue Next Year
- GLSI N/A
- DSP $15.32
- P/E Ratio
- GLSI N/A
- DSP $64.96
- Revenue Growth
- GLSI N/A
- DSP 30.92
- 52 Week Low
- GLSI $8.06
- DSP $8.19
- 52 Week High
- GLSI $15.47
- DSP $26.33
- Technical
- Relative Strength Index (RSI)
- GLSI 53.71
- DSP 37.04
- Support Level
- GLSI $9.73
- DSP $8.19
- Resistance Level
- GLSI $10.57
- DSP $8.85
- Average True Range (ATR)
- GLSI 0.57
- DSP 0.40
- MACD
- GLSI 0.02
- DSP 0.04
- Stochastic Oscillator
- GLSI 68.65
- DSP 29.05
About GLSI Greenwich LifeSciences Inc.
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.